Search

Nancy J. Leith

Examiner (ID: 17546, Phone: (313)446-4874 , Office: P/1636 )

Most Active Art Unit
1636
Art Unit(s)
1636, 1805, 1815, 1941, 1811
Total Applications
1477
Issued Applications
1013
Pending Applications
187
Abandoned Applications
292

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18144691 [patent_doc_number] => 20230018543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-19 [patent_title] => CRISPR/CAS-MEDIATED GENE CONVERSION [patent_app_type] => utility [patent_app_number] => 17/672387 [patent_app_country] => US [patent_app_date] => 2022-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 95289 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17672387 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/672387
CRISPR/CAS-MEDIATED GENE CONVERSION Feb 14, 2022 Abandoned
Array ( [id] => 17807771 [patent_doc_number] => 20220259606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-18 [patent_title] => METHODS OF MODULATING NUCLEIC ACID STABILITY AND PROTEIN EXPRESSION [patent_app_type] => utility [patent_app_number] => 17/590071 [patent_app_country] => US [patent_app_date] => 2022-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12501 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17590071 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/590071
METHODS OF MODULATING NUCLEIC ACID STABILITY AND PROTEIN EXPRESSION Jan 31, 2022 Abandoned
Array ( [id] => 17611888 [patent_doc_number] => 20220154167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-19 [patent_title] => METHODS AND COMPOSITIONS FOR ASSESSING PROTEIN FUNCTION [patent_app_type] => utility [patent_app_number] => 17/589081 [patent_app_country] => US [patent_app_date] => 2022-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11575 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17589081 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/589081
METHODS AND COMPOSITIONS FOR ASSESSING PROTEIN FUNCTION Jan 30, 2022 Pending
Array ( [id] => 19034515 [patent_doc_number] => 20240084330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-14 [patent_title] => COMPOSITIONS AND METHODS FOR DELIVERING CARGO TO A TARGET CELL [patent_app_type] => utility [patent_app_number] => 18/272158 [patent_app_country] => US [patent_app_date] => 2022-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 99228 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -72 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18272158 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/272158
COMPOSITIONS AND METHODS FOR DELIVERING CARGO TO A TARGET CELL Jan 27, 2022 Pending
Array ( [id] => 17946120 [patent_doc_number] => 20220333137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-20 [patent_title] => METHODS AND PRODUCTS FOR PRODUCING ENGINEERED MAMMALIAN CELL LINES WITH AMPLIFIED TRANSGENES [patent_app_type] => utility [patent_app_number] => 17/585694 [patent_app_country] => US [patent_app_date] => 2022-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21469 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17585694 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/585694
METHODS AND PRODUCTS FOR PRODUCING ENGINEERED MAMMALIAN CELL LINES WITH AMPLIFIED TRANSGENES Jan 26, 2022 Abandoned
Array ( [id] => 17595714 [patent_doc_number] => 20220145288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-12 [patent_title] => HTP GENOMIC ENGINEERING PLATFORM FOR IMPROVING FUNGAL STRAINS [patent_app_type] => utility [patent_app_number] => 17/584950 [patent_app_country] => US [patent_app_date] => 2022-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 100858 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 229 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17584950 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/584950
HTP GENOMIC ENGINEERING PLATFORM FOR IMPROVING FUNGAL STRAINS Jan 25, 2022 Abandoned
Array ( [id] => 17867430 [patent_doc_number] => 20220290166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-15 [patent_title] => EXPRESSION CONSTRUCTS AND METHODS OF GENETICALLY ENGINEERING METHYLOTROPHIC YEAST [patent_app_type] => utility [patent_app_number] => 17/584028 [patent_app_country] => US [patent_app_date] => 2022-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13449 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17584028 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/584028
Expression constructs and methods of genetically engineering methylotrophic yeast Jan 24, 2022 Issued
Array ( [id] => 17889818 [patent_doc_number] => 11452765 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-27 [patent_title] => Sequence specific antimicrobials [patent_app_type] => utility [patent_app_number] => 17/581614 [patent_app_country] => US [patent_app_date] => 2022-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 10633 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17581614 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/581614
Sequence specific antimicrobials Jan 20, 2022 Issued
Array ( [id] => 17595325 [patent_doc_number] => 20220144898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-12 [patent_title] => METHODS AND COMPOSITIONS FOR TREATING CANCER USING PEPTIDE NUCLEIC ACID-BASED AGENTS [patent_app_type] => utility [patent_app_number] => 17/581467 [patent_app_country] => US [patent_app_date] => 2022-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19058 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17581467 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/581467
METHODS AND COMPOSITIONS FOR TREATING CANCER USING PEPTIDE NUCLEIC ACID-BASED AGENTS Jan 20, 2022 Pending
Array ( [id] => 17579146 [patent_doc_number] => 20220136001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-05 [patent_title] => ARTIFICIAL NUCLEIC ACID MOLECULES [patent_app_type] => utility [patent_app_number] => 17/576583 [patent_app_country] => US [patent_app_date] => 2022-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40022 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -73 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17576583 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/576583
ARTIFICIAL NUCLEIC ACID MOLECULES Jan 13, 2022 Pending
Array ( [id] => 19543378 [patent_doc_number] => 20240360414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-31 [patent_title] => Systems and Methods for Base Editing Of HBG1/2 Gene Promoter and Fetal Hemoglobin Induction [patent_app_type] => utility [patent_app_number] => 18/272536 [patent_app_country] => US [patent_app_date] => 2022-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19383 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18272536 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/272536
Systems and Methods for Base Editing Of HBG1/2 Gene Promoter and Fetal Hemoglobin Induction Jan 13, 2022 Pending
Array ( [id] => 19624318 [patent_doc_number] => 12163125 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-10 [patent_title] => Engineered class 2 type V CRISPR systems [patent_app_type] => utility [patent_app_number] => 17/572208 [patent_app_country] => US [patent_app_date] => 2022-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 77 [patent_no_of_words] => 126604 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17572208 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/572208
Engineered class 2 type V CRISPR systems Jan 9, 2022 Issued
Array ( [id] => 17533899 [patent_doc_number] => 20220112508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-14 [patent_title] => INSTRUMENTS, MODULES, AND METHODS FOR IMPROVED DETECTION OF EDITED SEQUENCES IN LIVE CELLS [patent_app_type] => utility [patent_app_number] => 17/555395 [patent_app_country] => US [patent_app_date] => 2021-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56248 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17555395 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/555395
INSTRUMENTS, MODULES, AND METHODS FOR IMPROVED DETECTION OF EDITED SEQUENCES IN LIVE CELLS Dec 17, 2021 Abandoned
Array ( [id] => 18329526 [patent_doc_number] => 11634755 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-04-25 [patent_title] => Crispr enzymes and systems [patent_app_type] => utility [patent_app_number] => 17/554333 [patent_app_country] => US [patent_app_date] => 2021-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 345 [patent_figures_cnt] => 388 [patent_no_of_words] => 206996 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17554333 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/554333
Crispr enzymes and systems Dec 16, 2021 Issued
Array ( [id] => 18666554 [patent_doc_number] => 11773432 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-03 [patent_title] => CRISPR enzymes and systems [patent_app_type] => utility [patent_app_number] => 17/554314 [patent_app_country] => US [patent_app_date] => 2021-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 345 [patent_figures_cnt] => 388 [patent_no_of_words] => 206655 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17554314 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/554314
CRISPR enzymes and systems Dec 16, 2021 Issued
Array ( [id] => 18590406 [patent_doc_number] => 11739290 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-29 [patent_title] => Instruments, modules, and methods for improved detection of edited sequences in live cells [patent_app_type] => utility [patent_app_number] => 17/555336 [patent_app_country] => US [patent_app_date] => 2021-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 78 [patent_no_of_words] => 56241 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17555336 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/555336
Instruments, modules, and methods for improved detection of edited sequences in live cells Dec 16, 2021 Issued
Array ( [id] => 19381311 [patent_doc_number] => 20240271181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-15 [patent_title] => METHODS FOR DETECTING HOMOGENOUS TARGETS IN A POPULATION WITH NEXT GENERATION SEQUENCING [patent_app_type] => utility [patent_app_number] => 18/266692 [patent_app_country] => US [patent_app_date] => 2021-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15044 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18266692 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/266692
METHODS FOR DETECTING HOMOGENOUS TARGETS IN A POPULATION WITH NEXT GENERATION SEQUENCING Dec 9, 2021 Pending
Array ( [id] => 18085766 [patent_doc_number] => 11535887 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-12-27 [patent_title] => Methods for spatial analysis using targeted RNA depletion [patent_app_type] => utility [patent_app_number] => 17/546625 [patent_app_country] => US [patent_app_date] => 2021-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 38 [patent_no_of_words] => 36776 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17546625 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/546625
Methods for spatial analysis using targeted RNA depletion Dec 8, 2021 Issued
Array ( [id] => 17482594 [patent_doc_number] => 20220090098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-24 [patent_title] => GENETICALLY ENGINEERED VIBRIO SP. AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/541163 [patent_app_country] => US [patent_app_date] => 2021-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19338 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17541163 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/541163
GENETICALLY ENGINEERED VIBRIO SP. AND USES THEREOF Dec 1, 2021 Issued
Array ( [id] => 17474177 [patent_doc_number] => 20220081681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-17 [patent_title] => ENGINEERED PROTEINS [patent_app_type] => utility [patent_app_number] => 17/533997 [patent_app_country] => US [patent_app_date] => 2021-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 155522 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17533997 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/533997
Engineered proteins Nov 22, 2021 Issued
Menu